» Articles » PMID: 33920728

Thymoquinone Lowers Blood Glucose and Reduces Oxidative Stress in a Rat Model of Diabetes

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Apr 30
PMID 33920728
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to assess the short-term effects of Thymoquinone (TQ) on oxidative stress, glycaemic control, and renal functions in diabetic rats. DM was induced in groups II and III with a single dose of streptozotocin (STZ), while group I received no medication (control). The rats in groups I and II were then given distilled water, while the rats in group III were given TQ at a dose of 50 mg/kg body weight/day for 4 weeks. Lipid peroxidase, nitric oxide (NO), total antioxidant capacity (TAC), glycated haemoglobin (HbA1c), lipid profiles, and renal function were assessed. Moreover, the renal tissues were used for histopathological examination. STZ increased the levels of HbA1c, lipid peroxidase, NO, and creatinine in STZ-induced diabetic rats in comparison to control rats. TAC was lower in STZ-induced diabetic rats than in the control group. Furthermore, rats treated with TQ exhibited significantly lower levels of HbA1c, lipid peroxidase, and NO than did untreated diabetic rats. TAC was higher in diabetic rats treated with TQ than in untreated diabetic rats. The histopathological results showed that treatment with TQ greatly attenuated the effect of STZ-induced diabetic nephropathy. TQ effectively adjusts glycaemic control and reduces oxidative stress in STZ-induced diabetic rats without significant damaging effects on the renal function.

Citing Articles

Effects of Black Cumin Seed Extract on Pancreatic Islet β-Cell Proliferation and Hypoglycemic Activity in Streptozotocin-Induced Diabetic Rats.

Kim J, Chun Y, Yoon N, Kim B, Choi K, Ku S Antioxidants (Basel). 2025; 14(2).

PMID: 40002361 PMC: 11852139. DOI: 10.3390/antiox14020174.


Linalool exerts antioxidant activity in a rat model of diabetes by increasing catalase activity without antihyperglycemic effect.

Bar S, Kara M Exp Ther Med. 2024; 28(3):359.

PMID: 39071903 PMC: 11273359. DOI: 10.3892/etm.2024.12648.


Comprehensive and updated review on anti-oxidant effects of and its constituent, thymoquinone, in various disorders.

Aslani M, Saadat S, Boskabady M Iran J Basic Med Sci. 2024; 27(8):923-951.

PMID: 38911247 PMC: 11193497. DOI: 10.22038/IJBMS.2024.75985.16453.


Thymoquinone attenuates diabetes-induced hepatic damage in rat via regulation of oxidative/nitrosative stress, apoptosis, and inflammatory cascade with molecular docking approach.

Hafez M, Ez Elarab S, Tohamy H, El-Far A Sci Rep. 2024; 14(1):13016.

PMID: 38844763 PMC: 11156670. DOI: 10.1038/s41598-024-62780-y.


Self-micellizing solid dispersion of thymoquinone with enhanced biopharmaceutical and nephroprotective effects.

Halder S, Afrose S, Shill M, Sharmin N, Mollick P, Shuma M Drug Deliv. 2024; 31(1):2337423.

PMID: 38590120 PMC: 11005877. DOI: 10.1080/10717544.2024.2337423.


References
1.
Nauck M, Warnick G, Rifai N . Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem. 2002; 48(2):236-54. View

2.
Mullarkey C, Edelstein D, Brownlee M . Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. 1990; 173(3):932-9. DOI: 10.1016/s0006-291x(05)80875-7. View

3.
Mathe D . Dyslipidemia and diabetes: animal models. Diabete Metab. 1995; 21(2):106-11. View

4.
Asgary S, Sahebkar A, Goli-Malekabadi N . Ameliorative effects of Nigella sativa on dyslipidemia. J Endocrinol Invest. 2015; 38(10):1039-46. DOI: 10.1007/s40618-015-0337-0. View

5.
Groeneveld O, Kappelle L, Biessels G . Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus. J Diabetes Investig. 2016; 7(1):5-16. PMC: 4718099. DOI: 10.1111/jdi.12420. View